Feedback

European bodies faced pressure for approval of Pfizer vaccine, - Le Monde

Source : 112 Ukraine

Particularly, President of the European Commission Ursula von der Leyen stated about the necessity to approve Pfizer/BioNTech and Moderna vaccines
22:12, 19 January 2021

American biotech company Pfizer
Sky News

The European Medicines Agency (EMA) experienced pressure during the approval of the Pfizer vaccine, as Le Monde reported citing the classified documents of the regulator.

Some of the documents state that the quality of the drug was doubted by the EMA. However, some EU representatives continued to insist on the approval of the vaccine.

Related: Spain supports introduction of vaccination passports in EU

Particularly, President of the European Commission Ursula von der Leyen stated about the necessity to approve Pfizer/BioNTech and Moderna vaccines until the end of the year as an ultimatum as one of the EMA employees cited. It was underlined that ‘there still problems’ with both drugs.

However, the most difficulties appeared with the Pfizer vaccine. Especially after the detected fact of inconsistencies of the drug formula at commercial batches and batches used during clinical trials.

Related: Efficacy of Russia's second vaccine from coronavirus made 100 percent, - federal agency

Besides, the absence of the approval of some production platforms and lack of data on commercial batches of the vaccine raised the most concern.

As we reported, Pfizer vaccine apparently causes dozens of cases of side effects - specifically, in the Netherlands. Some patients in the Netherlands claimed allegric reactions, headache, fatigue and pain in the spot where the shot was made. The experts say that side effects during vaccination are quite natural, as the immune system responds after the injection.

Watch review of Year 2020 here:

 

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more